MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Funding Opportunities: Pioneers, Architects & Consolidators
Funding: U.S. Federal
*Funding: HHS
*HHS: Contracts, Contractors & Awards
*BARDA: Contracts (IDIQ, GWACS, Etc.), Contractors & Awardees
*Contractors & Awardees: BARDA
SIGA Technologies, Inc. (NASDAQ: SIGA)*
Organization & Developments: SIGA
Parents
SIGA Technologies, Inc. (NASDAQ: SIGA)*
Children
* Develops and sells pharmaceutical solutions for the antiviral treatment of smallpox, monkeypox, cowpox, and vaccinia complications
2015: SIGA Technologies: Uncovering Hidden Value In Bankruptcy_seekingalpha.com
2018: SIGA inks deal with USAMRIID to evaluate the efficacy of TPOXX as a PEP for smallpox
2018: SIGA Technologies receives BARDA contract worth $629M for TPOXX
2018: SIGA Technologies: A Buy For The Smallpox Treatment_seekingalpha.com
2018: SIGA Technologies: Undervalued After Receiving A Large Government Contract_seekingalpha.com
2022: SIGA Technologies Announces New Contract Awarded by U.S. Department of Defense for the Procurement of up to $10.7 Million of Oral TPOXX®
2022: SIGA Technologies: Solid Business With Means To Address Monkeypox Outbreak_seekingalpha.com
2023: US government to acquire $138M worth of Tpoxx doses
2024: Siga signs $113M US supply contract for mpox antiviral Tpoxx
2024: SIGA Technologies Lands $122M in New Orders, Sees $53.5M Revenue Surge in 2024
2024: SIGA Technologies Vs. Emergent BioSolutions: Product Portfolio And Future Outlook
2024: SIGA Technologies: Expansion Into mAbs Is Smart, But Eggs Remain In One Basket
2024: SIGA Technologies: Poised For A Potential Windfall From Monkeypox Emergency Declaration_ seekingalpha
2024: Siga Technologies: Preparing For A Contingency If Tomorrow Comes
2024: SIGA Technologies: Shares Tanking On Mpox Study Miss, Turbulence May Be Temporary
2025: SIGA Technologies: Still Bullish, But Worth Trimming Ahead Of BARDA News
Jumps
*Key People: SIGA
Finance & Acquisitions: SIGA